We Have More Than 40 Years of Experience. [email protected]
ban
new design sf6 voice in PUERTO RICO

new design sf6 voice in PUERTO RICO

Romark Announces FDA Approval Of New Manufacturing.20/8/2020· The Puerto Rico facility is strategic to the company's plans to manufacture and distribute its investigational new drug candidate, NT-300 (nitazoxanide extended-release tablets), which is.

[email protected]
CONTACT CONTACT US

Are You Looking for A Consultant?

toTop
Click avatar to contact us
Hi,may I help you with products, price, etc?
Chat Online